# FDA Inspection 868133 - Biomat USA, Inc. - February 28, 2014

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/dde15bbd-8197-437c-9317-112c1d4e5d87
Source feed: FDA_Inspections

> FDA Inspection 868133 for Biomat USA, Inc. on February 28, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 868133
- Company Name: Biomat USA, Inc.
- Inspection Date: 2014-02-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1252027 - 2024-10-28](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/8d1299d3-761e-48f0-9735-e3fb4df7e596)
- [FDA Inspection 1252027 - 2024-10-28](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/1332086a-73d8-41de-854c-b257cced2d88)
- [FDA Inspection 1071794 - 2018-10-30](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/d7730577-f89a-481e-8930-c4c79cad257e)
- [FDA Inspection 975112 - 2016-06-21](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/0de72395-b144-4b0d-8745-1d57c7702581)
- [FDA Inspection 709291 - 2011-02-11](https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/36b3d83b-8577-4193-8e3c-e8c0ca63829b)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/60e9910b-8a65-40d7-9b6a-ed3f04616e13

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
